170 related articles for article (PubMed ID: 35594550)
1. Simplifying Treatment Criteria in Chronic Hepatitis B: Reducing Barriers to Elimination.
Wong RJ; Kaufman HW; Niles JK; Kapoor H; Gish RG
Clin Infect Dis; 2023 Feb; 76(3):e791-e800. PubMed ID: 35594550
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
[TBL] [Abstract][Full Text] [Related]
3. Liver histopathological lesions is severe in patients with normal alanine transaminase and low to moderate hepatitis B virus DNA replication.
Jiang SW; Lian X; Hu AR; Lu JL; He ZY; Shi XJ; Zhu DD; Wang ZY; Huang GC
World J Gastroenterol; 2023 Apr; 29(16):2479-2494. PubMed ID: 37179582
[TBL] [Abstract][Full Text] [Related]
4. HBV DNA level could predict significant liver fibrosis in HBeAg negative chronic hepatitis B patients with biopsy indication.
Praneenararat S; Chamroonkul N; Sripongpun P; Kanngurn S; Jarumanokul R; Piratvisuth T
BMC Gastroenterol; 2014 Dec; 14():218. PubMed ID: 25523185
[TBL] [Abstract][Full Text] [Related]
5. Rates of Treatment Eligibility in Follow-Up of Patients with Chronic Hepatitis B (CHB) Across Various Clinical Settings Who Were Initially Ineligible at Presentation.
Uribe LA; Nguyen N; Kim L; Trinh HN; Wong C; Wong C; Nguyen LH; Nguyen MH
Dig Dis Sci; 2016 Feb; 61(2):618-25. PubMed ID: 26660679
[TBL] [Abstract][Full Text] [Related]
6. Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care center.
Jachs M; Sauberer R; Stiegler A; Dechêne A; Tazreiter R; Hartl L; Bauer D; Balcar L; Strassl R; Mandorfer M; Trauner M; Munda P; Ferenci P; Reiberger T
United European Gastroenterol J; 2023 Apr; 11(3):293-304. PubMed ID: 36965148
[TBL] [Abstract][Full Text] [Related]
7. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels.
Ormeci A; Aydın Y; Sumnu A; Baran B; Soyer OM; Pınarbasi B; Gokturk S; Gulluoglu M; Onel D; Badur S; Akyuz F; Karaca C; Demir K; Besisik F; Kaymakoglu S
Int J Infect Dis; 2016 Nov; 52():68-73. PubMed ID: 27619844
[TBL] [Abstract][Full Text] [Related]
8. ALT Levels in Treatment-Naive, Chronic Hepatitis B Patients with Concurrent Fatty Liver Disease: A US Nationwide Study.
Chang CY; Kam L; Dang N; Cheung R; Nguyen MH
Dig Dis; 2022; 40(4):497-505. PubMed ID: 34348281
[TBL] [Abstract][Full Text] [Related]
9. Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients.
Jeng WJ; Sheen IS; Chen YC; Hsu CW; Chien RN; Chu CM; Liaw YF
Hepatology; 2013 Dec; 58(6):1888-96. PubMed ID: 23744454
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic characteristics of liver inflammation and fibrosis in 310 patients with chronic hepatitis B.
Jiang C; Liu J; Li R; Chen K; Peng W; Fu L; Peng S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):698-706. PubMed ID: 37539572
[TBL] [Abstract][Full Text] [Related]
11. CLINICAL PHASES OF CHRONIC HEPATITIS B AMONG GEORGIAN PATIENTS.
Zakalashvili M; Butsashvili M; Zarkua J; Abzianidze T; Kamkamidze G; Metreveli D
Georgian Med News; 2022 Jan; (322):26-29. PubMed ID: 35134754
[TBL] [Abstract][Full Text] [Related]
12. Treatment eligibility of patients with chronic hepatitis B initially ineligible for therapy.
Nguyen NH; Nguyen V; Trinh HN; Lin B; Nguyen MH
Clin Gastroenterol Hepatol; 2013 May; 11(5):565-71. PubMed ID: 23333662
[TBL] [Abstract][Full Text] [Related]
13. Profiles of HBV DNA in a large population of Chinese patients with chronic hepatitis B: implications for antiviral therapy.
Fung J; Seto WK; Lai CL; Yuen J; Wong DK; Yuen MF
J Hepatol; 2011 Feb; 54(2):195-200. PubMed ID: 21056499
[TBL] [Abstract][Full Text] [Related]
14. Lower baseline ALT cut-off values and HBV DNA levels better differentiate HBeAg- chronic hepatitis B patients from inactive chronic carriers.
Assy N; Beniashvili Z; Djibre A; Nasser G; Grosovski M; Nseir W
World J Gastroenterol; 2009 Jun; 15(24):3025-31. PubMed ID: 19554656
[TBL] [Abstract][Full Text] [Related]
15. High-normal alanine aminotransferase is an indicator for liver histopathology in HBeAg-negative chronic hepatitis B.
Duan M; Chi X; Xiao H; Liu X; Zhuang H
Hepatol Int; 2021 Apr; 15(2):318-327. PubMed ID: 33638049
[TBL] [Abstract][Full Text] [Related]
16. Association of Cytokines with Alanine Aminotransferase, Hepatitis B Virus Surface Antigen and Hepatitis B Envelope Antigen Levels in Chronic Hepatitis B.
Li MH; Lu Y; Zhang L; Wang XY; Ran CP; Hao HX; Zhang D; Qu XJ; Shen G; Wu SL; Cao WH; Qi TL; Liu RY; Hu LP; Chang M; Hua WH; Liu SA; Wan G; Xie Y
Chin Med J (Engl); 2018 Aug; 131(15):1813-1818. PubMed ID: 30058578
[TBL] [Abstract][Full Text] [Related]
17. Similar efficacy and safety of tenofovir in Asians and non-Asians with chronic hepatitis B.
Pan CQ; Chan S; Trinh H; Yao A; Bae H; Lou L
World J Gastroenterol; 2015 May; 21(18):5524-31. PubMed ID: 25987775
[TBL] [Abstract][Full Text] [Related]
18. Liver Complications in Untreated Treatment-Ineligible versus Treated Treatment-Eligible Patients with Hepatitis B.
Huang DQ; Lee DH; Le MH; Le A; Yeo YH; Trinh HN; Chung M; Nguyen V; Johnson T; Zhang JQ; Wong C; Wong C; Li J; Cheung R; Nguyen MH
Dig Dis; 2023; 41(1):115-123. PubMed ID: 36070707
[TBL] [Abstract][Full Text] [Related]
19. Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: a prospective cohort study with paired transient elastography examination.
Wong GL; Chan HL; Yu Z; Chan HY; Tse CH; Wong VW
J Gastroenterol Hepatol; 2013 Dec; 28(12):1842-8. PubMed ID: 23829381
[TBL] [Abstract][Full Text] [Related]
20. Performance of risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B) score in classifying treatment eligibility under 2012 Asian Pacific Association for the Study of the Liver (APASL) guideline for chronic hepatitis B patients.
Chen TM; Chang CC; Huang PT; Wen CF; Lin CC
Aliment Pharmacol Ther; 2013 Jan; 37(2):243-51. PubMed ID: 23171385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
